Christoffer Rosen
Moelndal, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in ALS.
Journal: Journal of the neurological sciences
Published: December 15, 2023
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Journal: The Lancet. Neurology
Published: September 13, 2015
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 08, 2014
Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
Journal: Brain : a journal of neurology
Published: November 27, 2014
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival.
Journal: Neurology
Published: October 24, 2014
Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease.
Journal: Dementia and geriatric cognitive disorders extra
Published: September 26, 2014
Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry.
Journal: JAMA neurology
Published: February 26, 2014
Cerebrospinal fluid biomarkers in cardiac arrest survivors.
Journal: Resuscitation
Published: September 25, 2013
Fluid biomarkers in Alzheimer's disease - current concepts.
Journal: Molecular neurodegeneration
Published: April 19, 2013
Cerebrospinal fluid biomarkers for pathological processes in Alzheimer's disease.
Journal: Current opinion in psychiatry
Published: March 16, 2013
Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease.
Journal: Neuromolecular medicine
Published: September 27, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026